相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy of the CCR5 Antagonist Maraviroc in Reducing Early, Ritonavir-Induced Atherogenesis and Advanced Plaque Progression in Mice
Sabrina Cipriani et al.
CIRCULATION (2013)
Maraviroc reduces cytokine expression and secretion in human adipose cells without altering adipogenic differentiation
Julieta Diaz-Delfin et al.
CYTOKINE (2013)
Inflammation-Induced Hepatocellular Carcinoma Is Dependent on CCR5 in Mice
Neta Barashi et al.
HEPATOLOGY (2013)
Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
Laura Ochoa-Callejero et al.
PLOS ONE (2013)
Long-term glucose tolerance in highly experienced HIV-infected patients receiving nucleoside analogue-sparing regimens
Alba Bigoloni et al.
AIDS (2012)
CCR5 Plays a Critical Role in Obesity-Induced Adipose Tissue Inflammation and Insulin Resistance by Regulating Both Macrophage Recruitment and M1/M2 Status
Hironori Kitade et al.
DIABETES (2012)
Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus-coinfected patients
Juan Macias et al.
HEPATOLOGY (2012)
Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function
M. Pilar Valdecantos et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2012)
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Vincent Braunersreuther et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Maraviroc Can Improve Lipid Profiles in Dyslipidemic Patients with HIV: Results from the MERIT Trial
A. MacInnes et al.
HIV CLINICAL TRIALS (2011)
RANTES antagonism: A promising approach to treat chronic liver diseases
Silvia Affo et al.
JOURNAL OF HEPATOLOGY (2011)
Increasing burden of liver disease in patients with HIV infection
Deepak Joshi et al.
LANCET (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Hepatic Steatosis in Patients Coinfected with Human Immunodeficiency Virus/Hepatitis C Virus: A Meta-Analysis of the Risk Factors
Mariana Verdelho Machado et al.
HEPATOLOGY (2010)
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Marie-Luise Berres et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2010)
Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice
Kanji Yamaguchi et al.
LABORATORY INVESTIGATION (2010)
The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice
Livia de Fraia Pinto et al.
LIVER INTERNATIONAL (2010)
Functional role of chemokines in liver disease models
Hacer Sahin et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese Patients
Adeline Bertola et al.
PLOS ONE (2010)
Oral Pre-Exposure Prophylaxis by Anti-Retrovirals Raltegravir and Maraviroc Protects against HIV-1 Vaginal Transmission in a Humanized Mouse Model
C. Preston Neff et al.
PLOS ONE (2010)
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
Anna Wieckowska et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Relation of circulating concentrations of chemokine receptor CCR5 ligands to C-peptide, proinsulin and HbA1c and disease progression in type 1 diabetes
C. Pfleger et al.
CLINICAL IMMUNOLOGY (2008)
Atherogenic diet-induced hepatitis is partially dependent on murine TLR4
Moreshwar S. Desai et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study
Phyllis C. Tien et al.
AIDS (2007)
T-cell accumulation and regulated on activation, normal T cell expressed and secreted Upregulation in adipose tissue in obesity
Huaizhu Wu et al.
CIRCULATION (2007)
Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients
Barbara H. McGovern et al.
CLINICAL INFECTIOUS DISEASES (2006)
Impact of human immunodeficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection
Irphan Gaslightwala et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors
F Bani-Sadr et al.
AIDS (2006)
Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos Nutrition and Liver Study
G Bedogni et al.
HEPATOLOGY (2005)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Semiquantitative analysis of intrahepatic CC-chemokine mRNAs in chronic hepatitis C
HD Nischalke et al.
MEDIATORS OF INFLAMMATION (2004)
Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration
RF Schwabe et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma
E Bugianesi et al.
GASTROENTEROLOGY (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo et al.
HEPATOLOGY (2001)
RANTES: a versatile and controversial chemokine
V Appay et al.
TRENDS IN IMMUNOLOGY (2001)
分享论文
